Exclusive

Publication

Byline

Singapore Clinical Trial: CO45042: A Phase III, Randomized, Open-Label Study Evaluating the Efficacy and Safety of Divarasib Plus Pembrolizumab Versus Pembrolizumab And Pemetrexed And Carboplatin or Cisplatin in Patients with Previously Untreated, KRAS G12C-Mutated, Advanced Or Metastatic Non-Squamous Non-Small Cell Lung Cancer

Singapore, May 27 -- The Health Sciences Authority received information related to the study titled 'CO45042: A Phase III, Randomized, Open-Label Study Evaluating the Efficacy and Safety of Divarasib ... Read More


Singapore Clinical Trial: A Phase III, Open-label, Randomised Study of Datopotamab Deruxtecan (Dato-DXd) With or Without Durvalumab Compared with Investigator’s Choice of Chemotherapy (Paclitaxel, Nab-paclitaxel or Gemcitabine + Carboplatin) in Combination With Pembrolizumab in Patients with PD-L1 Positive Locally Recurrent Inoperable or Metastatic Triple-negative Breast Cancer (TROPION-Breast05)

Singapore, May 27 -- The Health Sciences Authority received information related to the study titled 'A Phase III, Open-label, Randomised Study of Datopotamab Deruxtecan (Dato-DXd) With or Without Durv... Read More


Singapore Clinical Trial: TulmiSTAR-01: A two-part, Phase I dose escalation and expansion followed by a randomized, open-label multicenter, Phase II study to assess the safety and efficacy of the combination of tulmimetostat (DZR123) and JSB462 (luxdegalutamide) vs standard of care in patients with progressive metastatic castrate resistant prostate cancer

Singapore, May 27 -- The Health Sciences Authority received information related to the study titled 'TulmiSTAR-01: A two-part, Phase I dose escalation and expansion followed by a randomized, open-labe... Read More


Singapore Clinical Trial: A Master Protocol of an Open-Label, Multi-Drug, Multi-Centre, Phase II Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Immunogenicity, and Antitumour Activity of Novel Combinations in Participants with Locally Advanced or Metastatic Non-Small Cell Lung Cancer (LIBRA)

Singapore, May 27 -- The Health Sciences Authority received information related to the study titled 'A Master Protocol of an Open-Label, Multi-Drug, Multi-Centre, Phase II Study to Evaluate the Safety... Read More


DRC faces 'catastrophic collision' of conflict and Ebola outbreak, WHO warns

France, May 27 -- "Eastern DRC now faces a catastrophic collision of disease and conflict, with the Ebola outbreak in Ituri province outpacing the response," Tedros Adhanom Ghebreyesus posted on X (fo... Read More


Karnataka Heading For Big Shake-Up: Siddaramaiah Likely To Resign Tomorrow, Will Shivakumar Take Over?

India, May 27 -- Intense political heat is being observed in Congress-ruled Karnataka. The two top senior leaders of the party, CM Siddaramaiah and DK Shivakumar, are again in the news over who will t... Read More


"India, Israel are great allies... need to join forces": Former Mossad agent Sagiv Asulin calls for global front against "Eighth Front" of narrative warfare

Tel Aviv, May 27 -- Highlighting the growing challenge of narrative manipulation, former Mossad agent Sagiv Asulin has called for major global cooperation between India and Israel to counter what he t... Read More


Russia's Ebola vaccine claim and its 'free cancer vaccine' promise: A comparison

New Delhi, May 27 -- The Russian Embassy in South Africa has claimed that scientists in their country have developed a vaccine against the new Ebola virus strain. As per the embassy, the announcement... Read More


FIFA World Cup 2026: What new rules have been introduced at the upcoming tournament? Check details here

New Delhi, May 27 -- Football is set to move on from time-wasting tactics ahead of the FIFA World Cup 2026 tournament. The upcoming FIFA World Cup in United States, Canada and Mexico will be the bigg... Read More


Zealand Pharma To Present ZUPREME-1 Results Of Petrelintide At ADA 2026

India, May 27 -- Zealand Pharma A/S (ZEAL.CO), a biotechnology company focused on advancing medicines for obesity and metabolic health, on Wednesday reported it will present its data from the obesity ... Read More